Table 1 from First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies
收藏Figshare2024-12-16 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_1_from_First-in-Human_Dose-Escalation_Study_of_Fianlimab_an_Antilymphocyte_Activation_Gene-3_Antibody_with_Cemiplimab_in_Patients_with_Advanced_Malignancies/28032358
下载链接
链接失效反馈官方服务：
资源简介：
Baseline characteristics and prior therapies.
创建时间：
2024-12-16
